Viewing Study NCT00066612


Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2025-12-26 @ 10:44 PM
Study NCT ID: NCT00066612
Status: COMPLETED
Last Update Posted: 2012-11-02
First Post: 2003-08-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy
Sponsor: SWOG Cancer Research Network
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: CDR0000316428
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View